What is Pleuropulmonary Blastoma ?

Pleuropulmonary blastoma, or PPB, is a rare and aggressive childhood cancer that develops in the lungs or the pleural cavity, which is the thin space surrounding the lungs. The tumor develops from immature lung tissue that serves as its origin during early development. Pleuropulmonary blastoma exists as a lung cancer variant that primarily affects infants and young children because of its different origins compared to common adult lung cancers, which arise from smoking and environmental factors.

This is an extremely uncommon cancer that belongs to the family of cancers affecting children whose origin is tissue that was either embryonic or incompletely developed. This cancer occurs during childhood because it originates from tissue that helps in the formation of the lungs.

The disease exhibits both uncommon clinical features and clinical significance, as its growth capacity allows it to invade multiple body regions, including the brain, bones, and liver. The early diagnosis and treatment process leads to better survival rates for patients.

The medical profession has made strides in diagnosing and treating pleuropulmonary blastoma, thanks to research in pediatric oncology, surgery, chemotherapy, and genetics. Kids suffering from the disease stand a chance of surviving if the disease is detected early enough.

How does Pleuropulmonary Blastoma differ from adult lung cancers?

Pleuropulmonary blastoma arises from primitive mesenchymal cells in the lung and pleural cavity. During fetal development, these cells produce the lung tissue they normally form. The cells start growing uncontrollably to create tumors after they experience genetic abnormalities.

The tumor starts as fluid-filled cysts located in the lung area, which later become solid cancerous tumors. Tumors that develop from immature cells exhibit rapid growth, enabling them to invade surrounding tissues.

What are the Types of Pleuropulmonary Blastoma ?

The types of pleuropulmonary blastoma tumors show distinct differences from the adult lung cancers, adenocarcinoma, and squamous cell carcinoma. The tumor develops as a pediatric sarcoma-like tumor that stems from lung connective tissue elements.

Research studies show that pleuropulmonary blastoma arises from mutations in the DICER1 gene, which is part of the genetic system that controls cell growth and development. The gene mutation increases the risk of developing rare tumors in young patients.

Doctors classify pleuropulmonary blastoma into three primary categories according to the tumor structure and its development stage.

Type I Pleuropulmonary Blastoma

Type I tumors are cystic lesions consisting mainly of air-filled or fluid-filled spaces within the lung. These tumors are usually diagnosed in infants or very young children.

The initial type of tumors shows less aggressive behavior but requires immediate intervention because the disease will progress to advanced stages. Surgical removal is necessary for these patients.

Type II Pleuropulmonary Blastoma

The tumors in Type II contain two distinct elements: cystic and solid material. These tumors develop an intermediate level of severity, which typically affects children who are older than the average age range.

Type II tumors demonstrate rapid growth patterns, which lead to the need for surgical treatment combined with chemotherapy.

Type III Pleuropulmonary Blastoma

Type III tumors are entirely solid masses and represent the most aggressive form of pleuropulmonary blastoma. The tumors exhibit rapid growth rates and have a tendency to spread to distant parts of the body.

The standard treatment for children who have type III tumors requires multiple medical procedures, including surgical interventions, chemotherapy treatments, and ongoing patient surveillance.

What are the Causes & Risk Factors of Pleuropulmonary Blastoma ?

The exact cause of pleuropulmonary blastoma is not always known. Researchers have discovered multiple genetic components that contribute to the development of this condition.

Genetic Mutations

The DICER1 gene causes pleuropulmonary blastoma through mutations. The gene regulates gene expression and cell development functions in the cellular system.

Gene mutations disrupt the normal control mechanisms that regulate cell growth, leading to tumor development.

Hereditary Conditions

The hereditary condition DICER1 syndrome increases the risk of developing rare tumors, including pleuropulmonary blastoma, which affects some children. The condition affects children. The condition includes:

• Pleuropulmonary blastoma
• Ovarian tumors
• Thyroid tumors
• Kidney tumors

Children with a family history of certain medical conditions need to receive specialized genetic counseling services along with ongoing medical assessments.

Age

Pleuropulmonary blastoma primarily affects young children who are usually less than six years old. Type I tumors occur in infants, while type II and III tumors occur later in life.

Environmental Factors

Pleuropulmonary blastoma develops differently from most adult lung cancers because it exists independently of both smoking and environmental pollution.

What are the Signs & Symptoms of Pleuropulmonary blastoma ?

The symptoms of pleuropulmonary blastoma depend on both the tumor size and its metastasis status.

Respiratory Symptoms

Patients experience breathing difficulties because the tumor grows in their lung or pleural space.

Common respiratory symptoms include:

• Persistent cough
• Shortness of breath
• Rapid breathing
• Chest pain
• Wheezing

The tumor disrupts lung function, which leads to respiratory infections in some children.

Fever &Fatigue

Children with pleuropulmonary blastoma may experience:

• Unexplained fever
• Fatigue
• Weakness

The body reacts to the tumor, leading to these symptoms.

Pneumothorax

Some cystic tumors can rupture and create a pneumothorax, which happens when air escapes into the pleural cavity and collapses the lung.

Symptoms of pneumothorax include:

• Sudden chest pain
• Difficulty breathing
• Rapid heart rate

The patient's condition requires urgent medical treatment.

Advanced Disease Symptoms

The body develops new symptoms when the tumor spreads to other regions of the body.

• Neurological signs/symptoms if the cancer spreads to the brain
• Bone pain, if it spreads to the bones
• Abdominal swelling, if it affects the abdominal organs

How is Pleuropulmonary Blastoma Diagnosed ?

Pleuropulmonary blastoma requires early diagnosis to enable effective treatment.

Physical Examination &Medical Background

The child's symptoms and medical history are reviewed by the doctors to start the diagnostic process. Chest abnormalities or unusual lung sounds may be found during the physical examination.

Imaging Studies

Different types of imaging tests are used to detect lung tumors based on their diagnostic accuracy.

X-ray of the chest

A chest X-ray may show lung abnormalities, such as masses and abnormal lung structures.

Computed Tomography (CT) Scan

CT scans provide comprehensive lung images that help medical professionals identify tumor dimensions, position, and features.

Magnetic Resonance Imaging (MRI)

MRI scans may be used to check for potential brain and tissue spread.

Biopsy

The diagnostic process requires a biopsy to confirm the medical condition. The doctor removes a tumor sample, which is analyzed under a microscope.

Pathologists examine tumor cells to identify their type and confirm the diagnosis of pleuropulmonary blastoma.

Genetic Testing

DICER1 gene mutation testing identifies hereditary risk factors, while genetic testing provides the basis for family-based screening programs.

What are the Stages of Pleuropulmonary Blastoma ?

Staging assesses how far the tumor has spread throughout the body, and this information helps medical professionals determine appropriate treatment methods.

Doctors evaluate:

• Tumor size
• Spread within the lung.
• Involvement of nearby lymph nodes
• Expands to distant organs such as the brain or bones.

How is Pleuropulmonary Blastoma Treated ?

The treatment of pleuropulmonary blastoma depends on both the tumor type and the disease stage, and the child's health condition.

Surgery

The main treatment approach for pleuropulmonary blastoma begins with surgical intervention, which doctors consider to be the most critical initial treatment.

The surgical procedure aims to achieve complete tumor removal together with any necessary lung tissue extraction.

The chances of survival become better when doctors conduct tumor removal procedures during the early stages of cancer development.

Chemotherapy

Chemotherapy works by administering powerful medications to destroy cancer cells.

Doctors use the treatment after surgery to eliminate any remaining cancer cells.

Doctors use it before surgery to reduce the size of major tumors.

For patients with advanced metastatic disease.

Pediatric sarcomas use common chemotherapy regimens that combine multiple drugs to treat pleuropulmonary blastoma.

Radiation Therapy

Radiation therapy may be used when tumors cannot be completely removed and when cancer has spread to other organs.

However, radiation use in children requires caution because of its potential to harm developing tissues in the long term.

What are the Possible Complications of Pleuropulmonary Blastoma ?

Pleuropulmonary blastoma can cause multiple medical complications.

Respiratory Problems

Breathing problems occur when large tumors block the lungs' normal function, making it difficult for patients to breathe.

Metastasis

Advanced tumors can spread their cells to distant organs, which include the brain, bones, and liver.

Recurrence

The tumor can return after treatment, which necessitates further monitoring and additional treatment.

Why is long-term medical follow-up necessary for Pleuropulmonary Blastoma?

Children who receive pleuropulmonary blastoma treatment need to undergo extended follow-up medical attention.

Follow-up may include:

• Regular imaging tests
• Monitoring for tumor recurrence
• Evaluation of lung function
• Screening for other tumors associated with DICER1 syndrome

The medical team can successfully treat recurrence when it is identified early in its development.

What is Prognosis of Pleuropulmonary Blastoma ?

The prognosis of pleuropulmonary blastoma depends on the tumors, which exist in different types and stages.

Children with Type I tumors generally have the best outcomes when doctors detect the tumor at an early stage and perform surgical removal.

Type II and Type III tumors show more aggressive behavior, which requires intensive treatment. The survival rates of pediatric patients have improved through these medical advances.

Patients who obtain early diagnosis, together with complete surgical tumor removal and correct chemotherapy treatment, will experience better chances of surviving for an extended period.

Why choose Tender Palm Super Speciality Hospital for Pleuropulmonary Blastoma Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Pleuropulmonary Blastoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced pediatric thoracic surgeons and neuro-oncology specialists who provide accurate diagnosis and both surgical and non-surgical treatment options including surgical resection, chemotherapy, and radiation therapy. Our Pediatric Thoracic Surgery and Oncology team has decades of experience in successfully treating Pleuropulmonary Blastoma in Lucknow, India.

To seek an Expert consultation for Pleuropulmonary Blastoma Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back